Concepedia

Evert Bosdriesz

EB

Statistics

Publications

14

Citations

1.5K

H-Index

14

Active since

2013

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Delft University of Technology

Vrije Universiteit Amsterdam

Cancer Genomics Centre

Evert Bosdriesz is an author at The Netherlands Cancer Institute specializing in oncology, life sciences, and molecular oncology.

Publications per year

2013–2020

14

Publications

14

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

Michael P. Menden, Dennis Wang, Mike J. Mason et al. · Nature Communications · 2019 · 363 citations · Full text

Medicine, Oncology, Pharmacology +16

An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential

Liqin Wang, Rodrigo Leite de Oliveira, Sanne C.F.A. Huijberts et al. · Cell · 2018 · 344 citations · Full text

Medicine, Cancer Biology, Oncology +16

How fast‐growing bacteria robustly tune their ribosome concentration to approximate growth‐rate maximization

Evert Bosdriesz, Douwe Molenaar, Bas Teusink et al. · FEBS Journal · 2015 · 264 citations · Full text

Life Sciences, Biochemistry, Microbiology +16

MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models

Xue Zheng, Daniël J. Vis, Alejandra Bruna et al. · Cell Research · 2018 · 133 citations · Full text

Medicine, Cancer Biology, Oncology +17

Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours

João M. Fernandes Neto, Ernest Nadal, Evert Bosdriesz et al. · Nature Communications · 2020 · 92 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 14